"N Engl J Med"[journal] 检索结果

941. Screening for Prostate Cancer with a Polygenic Risk Score. Reply.

作者: Elizabeth K Bancroft.;Jana K McHugh.;Rosalind A Eeles.
来源: N Engl J Med. 2025年393卷8期832页

942. Screening for Prostate Cancer with a Polygenic Risk Score.

作者: Harry D Green.;Leigh Jackson.;Sarah E R Bailey.
来源: N Engl J Med. 2025年393卷8期831-832页

943. Screening for Prostate Cancer with a Polygenic Risk Score.

作者: Chen-Yang Su.;Masashi Hasebe.
来源: N Engl J Med. 2025年393卷8期831页

944. Screening for Prostate Cancer with a Polygenic Risk Score.

作者: Martin Eklund.;Ian M Thompson.;Matthew R Cooperberg.
来源: N Engl J Med. 2025年393卷8期831页

945. AAV Gene Therapy in Severe Hemophilia B. Reply.

作者: Ulrike M Reiss.;Andrew M Davidoff.;Amit C Nathwani.
来源: N Engl J Med. 2025年393卷8期830页

946. AAV Gene Therapy in Severe Hemophilia B.

作者: Wolfgang Miesbach.;Flora Peyvandi.;Glenn F Pierce.
来源: N Engl J Med. 2025年393卷8期829-830页

947. Omitting Nodal Irradiation after Nodes Clear.

作者: Lior Z Braunstein.;Monica Morrow.
来源: N Engl J Med. 2025年393卷8期

948. Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. Reply.

作者: Arun J Sanyal.;Philip N Newsome.
来源: N Engl J Med. 2025年393卷8期827-828页

949. Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.

作者: Chen-Yang Su.;Masashi Hasebe.
来源: N Engl J Med. 2025年393卷8期827页

950. Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.

作者: Jesus Rivera-Esteban.;Víctor Valverde-Salazar.;José L Calleja.
来源: N Engl J Med. 2025年393卷8期827页

951. Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.

作者: James Lavender.;Steven Bollipo.;Nicholas Talley.
来源: N Engl J Med. 2025年393卷8期826页

952. Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.

作者: Susu Luo.;Hui Liu.;Wenyi Jin.
来源: N Engl J Med. 2025年393卷8期826页

953. Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy.

作者: Adolfo Aleman.;Oliver Van Oekelen.;David T Melnekoff.;Leah Grossman.;Tarek H Mouhieddine.;Agata Kurowski.;Ivan Odak.;Sidorela Reci.;Shriya Desai.;Shannon Meledathu.;Malini P Naidu.;Ravi P Shukla.;Rudra P Dutta.;Katerina Kappes.;Kseniya Serebryakova.;Hayley Jackson.;Jordan Lu.;Anastasia Chatikhine.;Raksha Kulkarni.;Zahra Moinfar.;Matthew M Croken.;Meenakshi Mehrotra.;Brett Baskovich.;Sampanna Rayamajhi.;Shambavi Richard.;Adriana C Rossi.;Christian Salib.;Jane Houldsworth.;Brian D Brown.;Miriam Merad.;Alessandro Laganà.;Patrick M Brunner.;Sundar Jagannath.;Joshua D Brody.;Samir Parekh.
来源: N Engl J Med. 2025年393卷8期823-825页

954. GM-CSF in Autoimmune Pulmonary Alveolar Proteinosis.

作者: John F Seymour.
来源: N Engl J Med. 2025年393卷8期812-816页

955. Redefining Lung Cancer Therapy - A Long-Awaited Shift in Strategy.

作者: Virginia Calvo.
来源: N Engl J Med. 2025年393卷8期809-810页

956. Case 24-2025: A 32-Year-Old Woman with Fatigue and Myalgias.

作者: Deborah Gomez Kwolek.;Julian S Haimovich.;Marc D Succi.;David M Dudzinski.;Sarah E Turbett.
来源: N Engl J Med. 2025年393卷8期799-807页

957. Abdominojugular Reflux Test.

作者: Stephen Bent.;Gurpreet Dhaliwal.
来源: N Engl J Med. 2025年393卷8期e10页

958. Educational Strategies for Clinical Supervision of Artificial Intelligence Use.

作者: Raja-Elie E Abdulnour.;Brian Gin.;Christy K Boscardin.
来源: N Engl J Med. 2025年393卷8期786-797页

959. Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis.

作者: Bruce C Trapnell.;Yoshikazu Inoue.;Francesco Bonella.;Tisha Wang.;Cormac McCarthy.;Toru Arai.;Keiichi Akasaka.;Francesca Mariani.;Nesrin Mogulkoc.;Jin Woo Song.;Tomohisa Baba.;Stephane Jouneau.;Tadahisa Numakura.;Nesrin Öcal.;Florin Mihaltan.;Ali Ataya.;Elisabeth Bendstrup.;Ilaria Campo.;Brenna Carey.;Ross Arena.;Brian Robinson.;Rosanna Fleming.;Yasmine Wasfi.;Raymond Pratt.; .
来源: N Engl J Med. 2025年393卷8期764-773页

Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease characterized by progressive surfactant accumulation and hypoxemia caused by autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF), which alveolar macrophages require to clear surfactant. Molgramostim is a formulation of inhaled recombinant human GM-CSF, but its efficacy and safety in patients with aPAP have not been studied sufficiently.

960. Cancer of Unknown Primary Site. Reply.

作者: Kanwal Raghav.
来源: N Engl J Med. 2025年393卷7期728页

结果排序

文献格式

出版时间

出版类型

出版语言